Related Articles
PD‑L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
Potential synergistic effects of sorafenib and CP‑31398 for treating anaplastic thyroid cancer with p53 mutations
Unveiling a novel biomarker panel for diagnosis and classification of well-differentiated thyroid carcinomas
Effects of HuR downregulation on anaplastic thyroid cancer cells